Track 5: Patient Engagement
This track addresses meaningful patient engagement in medical product development, from early product development, and approval, through maintenance phases. It focuses on important questions for all stakeholders, including:
- How do we meaningfully engage patients and incorporate their voices into decision-making throughout the medical product lifecycle?
- How do we become truly patient- (and people-) centric in our approach?
- How do we operationalize patient-centric approaches in our day-to-day work?
- How can we measure the effectiveness of our efforts, both for patient outcomes and to meet the needs of other stakeholders such as industry and regulatory decision-makers?
- What have we learned that can be used to drive more meaningful patient engagement?
- How do stakeholders best work together to leverage their collective power and expertise to promote meaningful involvement of patients?
Sessions in Patient Engagement
Monday, June 28
- Patient-Centric Engagement Strategies
- Ensuring Patient Engagement Methodologies Are ‘Fit for Purpose’ from the Beginning: A Key Factor for Meaningful Outcomes
- Patient-Led Special Initiatives
- Advancing the Science of Patient Input: How are WE doing? Multi-Stakeholder Perspective
Tuesday, June 29
- Pediatric Engagement in Research: Young People Have a Voice
- Navigating Non-Trial Preapproval Access as a Patient
- Patient Engagement in the Early Stage of Medicines’ Development: A Co-Created How-To Guide and its Piloting Results
- Diversity in Clinical Research: Practical Strategies for Taking Personal Action
- Parents Just Don’t Understand: Does This Apply to Healthcare Too?
Wednesday, June 30
- Patient Engagement and Quality by Design: Integrating the Patient Perspective in Clinical Trial Design
- The Intersection of Health Equity and Personalized Medicine
Thursday, July 1
- Patient-Focused Drug Development in Rare Diseases: Applying Guidances and Case Studies from the Field
- Patient Preference Studies and Meaningful Patient Engagement
Who is This Track Designed For?
Professionals involved in: patient affairs, patient advocacy, patient groups, patient support services, medical affairs (including CMOs and MSLs), clinical trial design and optimization, clinical research and operations, regulatory affairs, regulatory agency, corporate and government affairs, safety and pharmacovigilance, outcomes research, epidemiology, and Health Technology Assessment..